🔎 Trials Near Me

Beranda › Penyakit Paru › Nevada

Uji klinis Penyakit Paru di Nevada

6 studi untuk Penyakit Paru mencari peserta di lokasi di Nevada.

Kota di Nevada

Teks studi resmi (Bahasa Inggris)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Las Vegas Clinical Trials, North Las Vegas
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Henderson Clinical Trials, Henderson
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06977581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Comprehensive Cancer Centers of Nevada, Las Vegas
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Renown Regional Medical Center, Reno
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284602

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • Comprehensive Cancer Centers of Nevada - Central Valley - Twain, Las Vegas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05967689

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

  • PPD - Las Vegas Research Unit, Las Vegas
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07745907

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.